The Institute for Pharmacology and Preventive Medicine
The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.
Recent Activity / Publications in press
Tzamalis P, Herzberger V, Bergmann J, Wuerth A, Bramlage P, Schroefel H, Schmitt C, Schymik G. The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation – A three-year follow-up of the TAVIK registry. Cardiovasc Diabetol 2019.
Pfohl M, Pscherer S, Fritsche A, Anderten H, Borck A, Pegelow K, Bramlage P, Seufert J. Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL – a sub-analysis of the Titration and OPtimisation (TOP) registry. Diab Metab Obes 2019.
van Mark G, Lanzinger S, Sziegoleit S, Putz FJ, Durmaz M, Borscheller M, Danne T, Seufert J, Holl RW, Bramlage P.Characteristics of patients with type 1 or type 2 diabetes receiving insulin glargine U300 – an analysis of 7,268 patients based on the DPV and DIVE registries. Adv Ther 2019.
Hundertmark M, Williams T, Vogel A, Moritz M, Bramlage P, Pagonas N, Ritter O, Sasko B. Capnocytophaga canimorsus as cause of fatal sepsis. Case Rep Infect Dis 2019.
Frank D, Kennon S, Bonaros N, Romano M, Lefèvere T, Di Mario C, Stefàno P, Ribichini F, Himbert D, Urena-Alcazar M, Salgado-Fernandez J, Cuenca Castillo JJ, Garcia B, Kurucova J, Thoenes M, Lüske CM, Bramlage P, Styra R. A trial protocol for the validation of the “Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire” in patients undergoing Surgical Aortic Valve Replacement (SAVR) or Transfemoral (TF) Transcatheter Aortic Valve Implantation (TAVI) – The TASQ Registry. Open Heart 2019.
Cetinkaya A, Borsche A, Hein S, Bramlage P, Schönburg M, Richter M.Explantation and reimplantation of a breast implant to facilitate minimally invasive mitral valve surgery (MIMVS) and cryoablation of atrial fibrillation. Clin Case Rep 2019.
Nielsen NE, Baranowska J, Bramlage P, Baranowski J. Minimising the risk for left ventricular rupture during transcatheter aortic valve implantation by reducing stiff guidewires presence in the ventricle. ICVTS 2019.
Baumbach H, Schairer ER, Wachter K, Rustenbach C, Ahad S, Stan A, Hill S, Bramlage P, Franke UW, Schäufele T. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures. BMC Cardiovasc Disord 2019.
Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C. Patient preference for therapies in hypertension: a cross-sectional survey of German patients. Clin Res Cardiol 2019.
Bramlage P, Lanzinger S, van Mark G, Hess E, Fahrner S, Heyer CHJ, Friebe M, Seufert J, Danne T, Holl RW. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease – an analysis of the German DPV and DIVE databases. Cardiovascular Diabetology 2019.
PubMed listed Publications